Pinaverium Bromide
Title: Pinaverium Bromide
CAS Registry Number: 53251-94-8
CAS Name: 4-[(2-Bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]morpholinium bromide
Additional Names: 4-(6-bromoveratryl)-4-[2-[2-(6,6-dimethyl-2-norpinyl)ethoxy]ethyl]morpholinium bromide
Manufacturers' Codes: LAT-1717
Trademarks: Dicetel (Latema)
Molecular Formula: C26H41Br2NO4
Molecular Weight: 591.42
Percent Composition: C 52.80%, H 6.99%, Br 27.02%, N 2.37%, O 10.82%
Literature References: Spasmolytic agent with low incidence of anticholinergic effects. Prepn: BE 769469; R. Baronnet, US 3845048 (1971, 1974 both to Societe Berri-Balzac). Synthesis and pharmacology: R. Baronnet et al., Eur. J. Med. Chem. 9, 182 (1974). Pharmacodynamics: J. Bretaudeau et al., Therapie 30, 919 (1975). Synthesis of 14C pinaverium bromide and pharmacokinetics: C. Jacquot et al., Eur. J. Med. Chem. 13, 61 (1978). Mechanism of action: J. Bretaudeau, O. Foussard-Blanpin, J. Pharmacol. 11, 233 (1980). Inhibition of gastrointestinal contractile activity in dogs: Z. Itoh, T. Takahashi, Arzneim.-Forsch. 31, 1450 (1981). Effects in humans on gastric emptying and transit time: J. Bertrand et al., Therapie 36, 555 (1981).
Properties: Crystals from methyl ethyl ketone, mp 181°; also reported as mp ~170° (Baronnet, 1974). LD50 in mice (mg/kg): 1400 orally; 66 i.v. (Baronnet, 1974); also reported as LD50 i.v. in mice: 37 ±2.4 mg/kg (Baronnet et al.).
Melting point: mp 181°; mp ~170° (Baronnet, 1974)
Toxicity data: LD50 in mice (mg/kg): 1400 orally; 66 i.v. (Baronnet, 1974); LD50 i.v. in mice: 37 ±2.4 mg/kg (Baronnet et al.)
Therap-Cat: Antispasmodic.
Keywords: Antispasmodic.

Others monographs:
EtretinateMofebutazoneMedronic AcidFerrous Iodide
β-Bromoisovaleric Acid2-(2-Naphthyloxy)ethanolQuinic AcidAlpidem
Cyclohexanecarboxylic AcidMorpholineDimethylzincPimozide
Merisoprol Hg 197BentiromideIsoamyl BenzoateTinzaparin
©2016 DrugLead US FDA&EMEA